(E)-N,N-dimethyl-3-cyclohexylprop-2-enamide | 440357-54-0

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: (E)-N,N-dimethyl-3-cyclohexylprop-2-enamide
• 英文别名: 1-Cyclohexyl-3-dimethylamino-propenone；(E)-3-cyclohexyl-N,N-dimethylprop-2-enamide
• CAS: 440357-54-0
• 化学式: C₁₁H₁₉NO
• 分子量: 181.278
• InChiKey: UDPXLRPWODBUNQ-CMDGGOBGSA-N

物化性质

• 沸点：
  311.1±11.0 °C(Predicted)
• 密度：
  1.008±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.73
• 拓扑面积：
  20.3
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  (E)-N,N-dimethyl-3-cyclohexylprop-2-enamide 在 叔丁基过氧化氢 三苯胂氧化物 、 S-1,1'-联-2-萘酚 、 samarium(III) isopropoxide 作用下， 以 四氢呋喃 、 癸烷 为溶剂， 反应 6.0h， 生成 (2R,3S)-3-Cyclohexyl-oxirane-2-carboxylic acid dimethylamide
  参考文献：
  名称：

  Dynamic Ligand Exchange of the Lanthanide Complex Leading to Structural and Functional Transformation:  One-Pot Sequential Catalytic Asymmetric Epoxidation-Regioselective Epoxide-Opening Process

  摘要：

  The characteristic property of the lanthanide complex, which easily undergoes a dynamic ligand exchange and alters its structure and function in situ, is described. After the completion of the catalytic asymmetric epoxidation of various a,beta-unsaturated amides 2 in the presence of the Sm-(S)-BINOL-Ph3As=O (1:1:1) complex 1 (2-10 mol %), the addition of Me3SiN3 directly to the reaction mixture led to smooth epoxide-opening at room temperature, affording the corresponding anti-beta-azido-alpha-hydroxyamide 4 in excellent overall yield (up to 99%) with complete regioselectivity and excellent enantiomeric excess (up to >99%). The key to the success of the sequential process was the in situ generation of the highly reactive samarium azide complex through dynamic ligand exchange. In situ IR spectroscopy and other experiments provided strong evidence that the samariurn azide complex was generated. In addition, the relatively high Lewis basicity of the amide moiety had a key role in the high reactivity of both the epoxidation and the epoxide-opening reactions. Examinations of other nucleophiles such as sulfur or carbon nucleophiles as well as transformations of epoxide-opened products are also described.

  DOI：

  10.1021/ja043770+
• 作为产物：
  描述：

  N,N-二甲基乙酰胺 、 环己烷基甲醛 在 六氯环三磷腈 、 硫酸 作用下， 反应 25.0h， 以58%的产率得到(E)-N,N-dimethyl-3-cyclohexylprop-2-enamide
  参考文献：
  名称：

  使用磷腈基催化的酰胺的羟醛缩合反应

  摘要：

  我们已经开发出一种新的方法，用于使用1,3,5-三唑-2,4,6-三磷-2,2,4,4,6,6-六氯化物（TAPC）的磷直接将未活化的酰胺进行羟醛缩合/ SO 4 2-催化。反应混合物中的SO 4 2-物种提高了催化反应的速率。原则上，不需要金属源来生成催化剂，也不需要使用化学计量的酸或碱。该催化剂体系在相对酸性的条件下可操作。在酸性条件下进行反应的一个主要优点是醛和缩醛都能够通过脱水在酰胺羰基的α-碳上形成碳-碳键。

  DOI：

  10.1016/j.tetlet.2012.07.129

文献信息

• Lewis Acid Enabled Copper-Catalyzed Asymmetric Synthesis of Chiral β-Substituted Amides
  作者：Mamen Rodríguez-Fernández、Xingchen Yan、Juan F. Collados、Paul B. White、Syuzanna R. Harutyunyan

  DOI：10.1021/jacs.7b07344

  日期：2017.10.11

  are able to overcome the reactivity issues of unactivated enamides, known as the least reactive carboxylic acid derivatives, toward alkylation with organomagnesium reagents. Allowing unequaled chemo-reactivity and stereocontrol in catalytic asymmetric conjugate addition to enamides, the method is distinguished by its unprecedented reaction scope, allowing even the most challenging and synthetically

  在这里，我们报告说，容易获得的基于甲硅烷基和硼的路易斯酸与手性铜催化剂结合能够克服未活化的烯酰胺（被称为反应性最低的羧酸衍生物）对有机镁试剂进行烷基化的反应性问题。在催化不对称共轭加成到烯酰胺中允许无与伦比的化学反应性和立体控制，该方法以其前所未有的反应范围而著称，即使是最具挑战性和合成上重要的甲基化也能以良好的产率和出色的对映选择性完成。该催化协议可耐受较宽的温度范围（-78 °C 至环境温度）和放大（10 g），而手性催化剂可以重复使用而不会影响整体效率。
• Pyrazolopyrimidines as protein kinase inhibitors
  申请人：Paruch Kamil

  公开号：US20060094706A1

  公开（公告）日：2006-05-04

  In its many embodiments, the present invention provides a novel class of pyrazolo[1,5-a]pyrimidine compounds as inhibitors of protein and/or checkpoint kinases, methods of preparing such compounds, pharmaceutical compositions including one or more such compounds, methods of preparing pharmaceutical formulations including one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the protein or checkpoint kinases using such compounds or pharmaceutical compositions. The invention also relates to the inhibition of hepatitis C virus (HCV) replication. In particular, embodiments of the invention provide compounds and methods for inhibiting HCV RNA-dependent RNA polymerase enzymatic activity. The invention also provides compositions and methods for the prophylaxis and treatment of HCV infection.

  在其多种实施方式中，本发明提供了一种新型的吡唑并[1,5-a]嘧啶化合物类别，作为蛋白质和/或检查点激酶的抑制剂，制备这种化合物的方法，包括一种或多种这样的化合物的制药组合物，制备一种或多种这样的化合物的制药配方的方法，以及使用这样的化合物或制药组合物治疗、预防、抑制或改善与蛋白质或检查点激酶相关的一种或多种疾病的方法。本发明还涉及抑制丙型肝炎病毒（HCV）复制。具体而言，本发明的实施方式提供了化合物和方法，用于抑制HCV RNA依赖性RNA聚合酶酶活性。本发明还提供了用于预防和治疗HCV感染的组合物和方法。
• Pyrazolo[1,5a]pyrimidine compounds as antiviral agents
  申请人：Neogenesis Pharmaceuticals, Inc.

  公开号：US20040038993A1

  公开（公告）日：2004-02-26

  The invention relates to the inhibition of hepatitis C virus (HCV) replication. In particular, embodiments of the invention provide compounds and methods for inhibiting HCV RNA-dependent RNA polymerase enzymatic activity. The invention also provides compositions and methods for the prophylaxis and treatment of HCV infection.

  本发明涉及抑制丙型肝炎病毒（HCV）复制的方法。具体而言，本发明的实施例提供了抑制HCV RNA依赖性RNA聚合酶酶活性的化合物和方法。本发明还提供了用于预防和治疗HCV感染的组合物和方法。
• <i>Z</i>-Selective Synthesis of α,β-Unsaturated Amides with Triphenylsilylacetamides
  作者：Satoshi Kojima、Hiroki Inai、Tsugihiko Hidaka、Tomohide Fukuzaki、Katsuo Ohkata

  DOI：10.1021/jo0161936

  日期：2002.6.1

  With the purpose of developing a method of preparing Z-alpha,beta-unsaturated amides, the Peterson reaction of the (triphenylsilyl)acetamide Ph(3)SiGH(2)COX (1, X = NBn2; 3, X = NMe2) with various aldehydes was examined. The reaction of aromatic aldehydes gave selectivities up to > 97:3. It was found that the selectivity was a function of the electronic nature of the aromatic ring and higher Z selectivity was attained with electron-rich aldehydes. With aliphatic aldehydes selectivities up to 92:8 were achieved, and unlike with analogous phosphorus reagents, less sterically hindered aldehydes gave higher Z selectivity. Also, 3, which has a smaller amide group than 1, tended to give rise to higher selectivity. A comparison with the reaction of trimethylsilyl analogues revealed the significance of the phenyl substituents on the silyl group.
• PYRAZOLO[1,5-A]PYRIMIDINE COMPOUNDS AS ANTIVIRAL AGENTS
  申请人：Neogenesis Pharmaceuticals, Inc.

  公开号：EP1511751B1

  公开（公告）日：2008-03-19